Aqueous Phenol (use of 6%) in Unlicensed Indications in Pathological Muscle Hypertonia (611)

Warning

A guideline is intended to assist healthcare professionals in the choice of disease-specific treatments.

Clinical judgement should be exercised on the applicability of any guideline, influenced by individual patient characteristics. Clinicians should be mindful of the potential for harmful polypharmacy and increased susceptibility to adverse drug reactions in patients with multiple morbidities or frailty.

If, after discussion with the patient or carer, there are good reasons for not following a guideline, it is good practice to record these and communicate them to others involved in the care of the patient.

Resources

Use the button below to access this item.

Access this resource

Editorial Information

Last reviewed: 24/05/2023

Next review date: 31/07/2025

Author(s): Alison Barclay.

Version: 3

Author email(s): alison.barclay@ggc.scot.nhs.uk.

Approved By: Regional Services Clinical Governance Group

Reviewer name(s): Alison Barclay.

Document Id: 611

Related resources

ALTER, K., HALLETT, M., KARP,B. & LUNGU, C., 2013.  Ultrasound-Guided Chemodenervation procedures text and atlas.  New York, Demos Medical Publishing.

GAID, M., 2012. Phenol Nerve Block for the Management of Lower Limb Spasticity.  ACNR. 12(3), pp. 23-5.

ROY, C. 2012.  Phenol Block for Upper Limb Spasticity. ACNR [online].  [viewed 19 February 2016].  Available from: http://www.acnr.co.uk/2012/12/phenol-block-for-upper-limb-spasticity/

KEENAN, M., 1998.  Management of the spastic upper extremity in the neurologically impaired adult. Clinical Orthopaedics and Related Research233, pp. 116-25.

ELOVIC, E., ESQUENAZI, A., ALTER, K., LIN, J., ALFARO, A & KAELIN, D., 2009.  Chemodenervation and nerve blocks in the diagnosis and management of spasticity and muscle overactivity.  The American Academy of Physical Medicine and Rehabilitation1, pp. 842-851.

DEMIR, Y., SAN, AU., KESIKBURN, S., YASAR, E., & YILMAZ, B., 2018. The short-term effect of ultrasound and peripheral nerve stimulator-guided femoral nerve block with phenol on the outcomes of patients with traumatic spinal cord injury.  Spinal Cord56(9): pp907-912.